1
/
of
1
Elabscience
SKU:E-CL-H0137
Human PAPPA(Pappalysin-1) CLIA Kit
Human PAPPA(Pappalysin-1) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human PAPPA (Pappalysin-1) CLIA Kit, a cutting-edge solution designed to accurately measure the levels of Pappalysin-1 in human samples. This advanced kit utilizes Chemiluminescent Immunoassay (CLIA) technology, ensuring precise and reliable results for researchers and clinicians alike.
Pappalysin-1, also known as PAPPA, is a key enzyme involved in various physiological processes, including tissue remodeling, growth regulation, and insulin-like growth factor (IGF) signaling. Its dysregulation has been implicated in numerous diseases, making it a crucial biomarker for diagnostic and therapeutic purposes.
The Human PAPPA CLIA Kit offers a comprehensive and user-friendly approach to quantifying Pappalysin-1 levels in human samples. With its high sensitivity and specificity, this kit enables accurate detection and quantification of Pappalysin-1, even at low concentrations. Its wide dynamic range ensures optimal performance across a broad spectrum of sample types, allowing for versatile applications in diverse research fields.
This CLIA kit includes all necessary components, including pre-coated microplates, standards, controls, and reagents, ensuring convenience and ease of use. The step-by-step protocol provided guarantees a streamlined workflow, minimizing errors and maximizing efficiency. Furthermore, the kit's robust design ensures long-term stability and reproducibility, ensuring consistent and reliable results over time.
The Human PAPPA CLIA Kit is an indispensable tool for researchers and clinicians seeking to unravel the intricate mechanisms underlying Pappalysin-1's role in various diseases. Its accurate and precise quantification capabilities provide valuable insights into disease progression, therapeutic efficacy, and patient stratification. Whether investigating Pappalysin-1's involvement in cancer, cardiovascular disorders, or reproductive health, this kit empowers researchers to make informed decisions and advance scientific knowledge.
In summary, the Human PAPPA CLIA Kit offers a state-of-the-art solution for the quantification of Pappalysin-1 in human samples. Its advanced CLIA technology, user-friendly design, and reliable performance make it an indispensable tool for researchers and clinicians alike. Unlock the potential of Pappalysin-1 and revolutionize your research with this exceptional CLIA kit.
Pappalysin-1, also known as PAPPA, is a key enzyme involved in various physiological processes, including tissue remodeling, growth regulation, and insulin-like growth factor (IGF) signaling. Its dysregulation has been implicated in numerous diseases, making it a crucial biomarker for diagnostic and therapeutic purposes.
The Human PAPPA CLIA Kit offers a comprehensive and user-friendly approach to quantifying Pappalysin-1 levels in human samples. With its high sensitivity and specificity, this kit enables accurate detection and quantification of Pappalysin-1, even at low concentrations. Its wide dynamic range ensures optimal performance across a broad spectrum of sample types, allowing for versatile applications in diverse research fields.
This CLIA kit includes all necessary components, including pre-coated microplates, standards, controls, and reagents, ensuring convenience and ease of use. The step-by-step protocol provided guarantees a streamlined workflow, minimizing errors and maximizing efficiency. Furthermore, the kit's robust design ensures long-term stability and reproducibility, ensuring consistent and reliable results over time.
The Human PAPPA CLIA Kit is an indispensable tool for researchers and clinicians seeking to unravel the intricate mechanisms underlying Pappalysin-1's role in various diseases. Its accurate and precise quantification capabilities provide valuable insights into disease progression, therapeutic efficacy, and patient stratification. Whether investigating Pappalysin-1's involvement in cancer, cardiovascular disorders, or reproductive health, this kit empowers researchers to make informed decisions and advance scientific knowledge.
In summary, the Human PAPPA CLIA Kit offers a state-of-the-art solution for the quantification of Pappalysin-1 in human samples. Its advanced CLIA technology, user-friendly design, and reliable performance make it an indispensable tool for researchers and clinicians alike. Unlock the potential of Pappalysin-1 and revolutionize your research with this exceptional CLIA kit.
Share
